NCT07166887View on ClinicalTrials.gov

Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 7, 2011

Primary Completion Date

July 27, 2011

Study Completion Date

July 27, 2011

Conditions
Healthy Subjects
Interventions
DRUG

Tolvaptan

One dose on the first day and one dose on days 3-9, for a total of eight doses.

Sponsors
All Listed Sponsors
lead

Otsuka Beijing Research Institute

INDUSTRY